TMEM45A Knockout Lentivirus(TMEM45A基因敲除慢病毒)是一种感染动物细胞后可以同时表达Cas9、目的基因sgRNA和puromycin抗性基因的慢病毒。本产品用于在动物细胞中基于CRISPR/Cas9技术敲除目的基因,并且本慢病毒中sgRNA的有效性已经通过T7EI法的验证。
本慢病毒基因序列的关键图谱信息请参考图1。本慢病毒可用于感染细胞或组织并进行目的基因的CRISPR/Cas9敲除。
图1. 可同时表达sgRNA、Cas9和puromycin抗性的本慢病毒其基因序列的关键图谱信息。
用于包装本慢病毒的质粒中的sgRNA基于碧云天研发的CRISPR/Cas9 sgRNA快速筛选和验证体系获得,sgRNA的有效性已经通过T7EI法验证。
本慢病毒用于实验时,建议同时选购无任何靶向的对照慢病毒Control Knockout Lentivirus (L00015)或靶向GFP的对照慢病毒GFP Knockout Lentivirus (L00017)。
碧云天同时提供基于CRISPR/Cas9技术的TMEM45A基因敲除的质粒(L13820 pLenti-TMEM45A-sgRNA)、慢病毒(L13821 TMEM45A Knockout Lentivirus)、HEK293T细胞(L13822 TMEM45A Knockout HEK293T Cells)、HEK293T敲除细胞的RIPA裂解液(L13823 TMEM45A Knockout HEK293T RIPA Lysate)、HEK293T敲除细胞的Trizol裂解液(L13824 TMEM45A Knockout HEK293T Trizol Lysate)等产品,具体请在碧云天网站查询或在本产品网页点击相应产品。
TMEM45A基因的基本信息如下:
Species | Gene Symbol | Gene ID | GenBank Accession | Transcript |
Human | TMEM45A | 55076 | BC040355 | NM_018004 |
About the gene | |
Official Symbol | TMEM45A |
Previous Symbol | - |
Official Full Name | transmembrane protein 45A |
Synonyms | FLJ10134; DERP7 |
Location | 3q12.2 |
Gene Type | protein-coding gene |
Uniprot ID | Q9NWC5 |
Pathway/Library | Lung Cancer Growth Related Genes Library |
Gene Summary | TMEM45A is a transmembrane protein involved in tumor progression and cancer resistance to chemotherapeutic agents in hypoxic condition. It is correlated to a low breast cancer patient overall survival. The messenger RNA expression of TMEM45A was assessed in head and neck squamous cell carcinoma (HNSCC) and renal cell carcinoma (RCC) biopsies. TMEM45A was upregulated in patients diagnosed for head and neck or renal cancer. Then, the implication of this protein in cisplatin sensitivity was explored in SQD9 and RCC4 + pVHL cells. TMEM45A inactivation decreased cell proliferation and modulated cell responses to cisplatin. TMEM45A inactivation increased the sensitivity of SQD9 cells to cisplatin, whereas it rendered RCC4 + pVHL cells resistant to this anticancer agent. There was an anti or a pro-apoptotic role of this protein depending on the cancer type and highlighted the role of TMEM45A in modulating patient responses to treatment. |
产品编号 | 产品名称 | 包装 |
L13821 | TMEM45A Knockout Lentivirus | 108 TU |
— | 说明书 | 1份 |
-80℃保存,至少一年有效。
注意事项:碧云天拥有sgRNA序列的知识产权,如果需要sgRNA序列,请在订购后发送邮件向info@beyotime.com索取。sgRNA序列信息与本慢病毒,未经碧云天书面许可不得用于任何商业用途,也不得移交给订货人所在实验室外的任何个人或单位。使用者在发表研究论文或结果时,应注明来源。
对于非目录产品的CRISPR基因敲除用的慢病毒的定制,可联系碧云天技术服务service@beyotime.com。
本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。
为了您的安全和健康,请穿实验服并戴一次性手套操作。
产品编号 | 产品名称 | 包装 |
L00015 | Control Knockout Lentivirus | 108 TU |
L00017 | GFP Knockout Lentivirus | 108 TU |
C0222 | 青霉素-链霉素溶液(100X) | 100ml |
C0351-1ml | Polybrene (Hexadimethrine Bromide) | 1ml |
C0351-50mg | Polybrene (Hexadimethrine Bromide) | 50mg |
D0508S/M | 基因组编辑突变检测试剂盒 | 25/100次 |
D7080S/M/L | T7 Endonuclease I (CRISPR等基因突变鉴定用) | 250/1250/5000U |
ST551-10mg | Puromycin Dihydrochloride (嘌呤霉素) | 10mg/ml×1ml |
ST551-50mg | Puromycin Dihydrochloride (嘌呤霉素) | 10mg/ml×5ml |
ST551-250mg | Puromycin Dihydrochloride (嘌呤霉素) | 250mg |
ST1380-500mg | Polybrene (≥94%, Reagent grade) | 500mg |
ST1380-2g | Polybrene (≥94%, Reagent grade) | 2g |
ST1380-10g | Polybrene (≥94%, Reagent grade) | 10g |